Literature DB >> 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.

A Hunter Shain1, Nancy M Joseph2, Richard Yu3, Jamal Benhamida2, Shanshan Liu3, Tarl Prow4, Beth Ruben5, Jeffrey North6, Laura Pincus6, Iwei Yeh7, Robert Judson3, Boris C Bastian8.   

Abstract

We elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-malignant lesions by sequencing DNA and RNA from primary melanomas and their adjacent precursors, as well as matched primary tumors and regional metastases. In total, we analyzed 230 histopathologically distinct areas of melanocytic neoplasia from 82 patients. Somatic alterations sequentially induced mitogen-activated protein kinase (MAPK) pathway activation, upregulation of telomerase, modulation of the chromatin landscape, G1/S checkpoint override, ramp-up of MAPK signaling, disruption of the p53 pathway, and activation of the PI3K pathway; no mutations were specifically associated with metastatic progression, as these pathways were perturbed during the evolution of primary melanomas. UV radiation-induced point mutations steadily increased until melanoma invasion, at which point copy-number alterations also became prevalent.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA-seq; RNA-seq; dysplastic nevus; genomic; melanoma; metastasis; nevus; transcriptomic; tumor evolution; tumor progression

Mesh:

Substances:

Year:  2018        PMID: 29990500      PMCID: PMC6319271          DOI: 10.1016/j.ccell.2018.06.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  35 in total

1.  Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.

Authors:  Boris G Wilson; Xi Wang; Xiaohua Shen; Elizabeth S McKenna; Madeleine E Lemieux; Yoon-Jae Cho; Edward C Koellhoffer; Scott L Pomeroy; Stuart H Orkin; Charles W M Roberts
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

2.  Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.

Authors:  J Zachary Sanborn; Jongsuk Chung; Elizabeth Purdom; Nicholas J Wang; Hojabr Kakavand; James S Wilmott; Timothy Butler; John F Thompson; Graham J Mann; Lauren E Haydu; Robyn P M Saw; Klaus J Busam; Roger S Lo; Eric A Collisson; Joe S Hur; Paul T Spellman; James E Cleaver; Joe W Gray; Nam Huh; Rajmohan Murali; Richard A Scolyer; Boris C Bastian; Raymond J Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

Review 3.  The INK4a/ARF locus and melanoma.

Authors:  E Sharpless; Lynda Chin
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

4.  Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Authors:  Thomas Botton; Iwei Yeh; Tyrrell Nelson; Swapna S Vemula; Alyssa Sparatta; Maria C Garrido; Maryline Allegra; Stephane Rocchi; Philippe Bahadoran; Timothy H McCalmont; Philip E LeBoit; Elizabeth A Burton; Gideon Bollag; Robert Ballotti; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2013-08-19       Impact factor: 4.693

5.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

6.  c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes.

Authors:  G Monsel; N Ortonne; M Bagot; A Bensussan; N Dumaz
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

7.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.

Authors:  Eric Talevich; A Hunter Shain; Thomas Botton; Boris C Bastian
Journal:  PLoS Comput Biol       Date:  2016-04-21       Impact factor: 4.475

8.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Authors:  Michael Krauthammer; Yong Kong; Byung Hak Ha; Perry Evans; Antonella Bacchiocchi; James P McCusker; Elaine Cheng; Matthew J Davis; Gerald Goh; Murim Choi; Stephan Ariyan; Deepak Narayan; Ken Dutton-Regester; Ana Capatana; Edna C Holman; Marcus Bosenberg; Mario Sznol; Harriet M Kluger; Douglas E Brash; David F Stern; Miguel A Materin; Roger S Lo; Shrikant Mane; Shuangge Ma; Kenneth K Kidd; Nicholas K Hayward; Richard P Lifton; Joseph Schlessinger; Titus J Boggon; Ruth Halaban
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

9.  Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Authors:  Michael Krauthammer; Yong Kong; Antonella Bacchiocchi; Perry Evans; Natapol Pornputtapong; Cen Wu; Jamie P. McCusker; Shuangge Ma; Elaine Cheng; Robert Straub; Merdan Serin; Marcus Bosenberg; Stephan Ariyan; Deepak Narayan; Mario Sznol; Harriet M Kluger; Shrikant Mane; Joseph Schlessinger; Richard P Lifton; Ruth Halaban
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 41.307

10.  Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.

Authors:  Jakob Hedegaard; Kasper Thorsen; Mette Katrine Lund; Anne-Mette K Hein; Stephen Jacques Hamilton-Dutoit; Søren Vang; Iver Nordentoft; Karin Birkenkamp-Demtröder; Mogens Kruhøffer; Henrik Hager; Bjarne Knudsen; Claus Lindbjerg Andersen; Karina Dalsgaard Sørensen; Jakob Skou Pedersen; Torben Falck Ørntoft; Lars Dyrskjøt
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more
  49 in total

1.  Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.

Authors:  Eunmiri Roh; Yaping Han; Kanamata Reddy; Tatyana A Zykova; Mee Hyun Lee; Ke Yao; Ruihua Bai; Clara Curiel-Lewandrowski; Zigang Dong
Journal:  Oncogene       Date:  2020-04-10       Impact factor: 9.867

2.  Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.

Authors:  Qiang Ju; Yan-Jie Zhao; Sai Ma; Xin-Mei Li; Heng Zhang; Shao-Qiang Zhang; Yuan-Ming Yang; Song-Xia Yan
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-30       Impact factor: 4.553

3.  Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.

Authors:  Jana Travnickova; Sonia Wojciechowska; Ava Khamseh; Philippe Gautier; Daniel V Brown; Thomas Lefevre; Alessandro Brombin; Ailith Ewing; Amy Capper; Michaela Spitzer; Ramile Dilshat; Colin A Semple; Marie E Mathers; James A Lister; Eiríkur Steingrimsson; Thierry Voet; Chris P Ponting; E Elizabeth Patton
Journal:  Cancer Res       Date:  2019-10-03       Impact factor: 12.701

Review 4.  Prognostic Biomarkers for Melanoma Immunotherapy.

Authors:  Christopher G Twitty; Laura A Huppert; Adil I Daud
Journal:  Curr Oncol Rep       Date:  2020-02-11       Impact factor: 5.075

5.  Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.

Authors:  Hanlin Zeng; Aparna Jorapur; A Hunter Shain; Ursula E Lang; Rodrigo Torres; Yuntian Zhang; Andrew S McNeal; Thomas Botton; Jue Lin; Matthew Donne; Ingmar N Bastian; Richard Yu; Jeffrey P North; Laura Pincus; Beth S Ruben; Nancy M Joseph; Iwei Yeh; Boris C Bastian; Robert L Judson
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

Review 6.  The Evolution of Melanoma - Moving beyond Binary Models of Genetic Progression.

Authors:  Hanlin Zeng; Robert L Judson-Torres; A Hunter Shain
Journal:  J Invest Dermatol       Date:  2019-10-14       Impact factor: 8.551

Review 7.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

8.  MicroRNA Ratios Distinguish Melanomas from Nevi.

Authors:  Rodrigo Torres; Ursula E Lang; Miroslav Hejna; Samuel J Shelton; Nancy M Joseph; A Hunter Shain; Iwei Yeh; Maria L Wei; Michael C Oldham; Boris C Bastian; Robert L Judson-Torres
Journal:  J Invest Dermatol       Date:  2019-09-30       Impact factor: 8.551

9.  BRN 2 Invade.

Authors:  Gaurav Pathria; Ze'ev A Ronai
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

Review 10.  Squaring the circle: circRNAs in melanoma.

Authors:  Nicol Mecozzi; Olga Vera; Florian A Karreth
Journal:  Oncogene       Date:  2021-07-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.